Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Highly Efficient Knockout of a Squid Pigmentation Gene.
Crawford K, Diaz Quiroz JF, Koenig KM, Ahuja N, Albertin CB, Rosenthal JJC. Crawford K, et al. Among authors: ahuja n. Curr Biol. 2020 Sep 7;30(17):3484-3490.e4. doi: 10.1016/j.cub.2020.06.099. Epub 2020 Jul 30. Curr Biol. 2020. PMID: 32735817 Free PMC article.
Creation of an albino squid line by CRISPR-Cas9 and its application for in vivo functional imaging of neural activity.
Ahuja N, Hwaun E, Pungor JR, Rafiq R, Nemes S, Sakmar T, Vogt MA, Grasse B, Diaz Quiroz J, Montague TG, Null RW, Dallis DN, Gavriouchkina D, Marletaz F, Abbo L, Rokhsar DS, Niell CM, Soltesz I, Albertin CB, Rosenthal JJC. Ahuja N, et al. Curr Biol. 2023 Jul 10;33(13):2774-2783.e5. doi: 10.1016/j.cub.2023.05.066. Epub 2023 Jun 20. Curr Biol. 2023. PMID: 37343558
Nuclear Receptor Rev-erbα Role in Fine-Tuning Erythropoietin Gene Expression.
Kumar S, Arora R, Gupta S, Ahuja N, Bhagyaraj E, Nanduri R, Kalra R, Khare AK, Kumawat S, Kaushal V, Sharma M, Gupta P. Kumar S, et al. Among authors: ahuja n. Blood Adv. 2024 May 15:bloodadvances.2023012228. doi: 10.1182/bloodadvances.2023012228. Online ahead of print. Blood Adv. 2024. PMID: 38748870
SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Lane HC, Beigel J, Dodd LE; Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members. Singh K, et al. J Infect Dis. 2024 Apr 24:jiae198. doi: 10.1093/infdis/jiae198. Online ahead of print. J Infect Dis. 2024. PMID: 38657001
611 results